These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 36083490

  • 1. Effect of treatment with Fufang Huangqi decoction on dose reductions and discontinuation of pyridostigmine bromide tablets, prednisone, and tacrolimus in patients with type I or II myasthenia gravis.
    Caifeng S, Jingsheng Z, Yi L, Xueshi H, Zhanyou W, Haiou P, Wenjun Q.
    J Tradit Chin Med; 2022 Oct; 42(5):810-817. PubMed ID: 36083490
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
    Tripathi M, Kaushik S, Dubey P.
    J Postgrad Med; 2003 Oct; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
    [Abstract] [Full Text] [Related]

  • 6. The effectiveness and side effects of pyridostigmine in the treatment of myasthenia gravis: a cross-sectional study.
    Remijn-Nelissen L, Verschuuren JJGM, Tannemaat MR.
    Neuromuscul Disord; 2022 Oct; 32(10):790-799. PubMed ID: 36184373
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic efficacy and immunoregulatory effect of Qiangji Jianli Capsule for patients with myasthenia gravis: Study protocol for a series of randomized, controlled N-of-1 trials.
    Weng S, Fan Z, Qiu G, Liu F, Huang L, Li J, Jiang X, Song Z, Gao Y, Zhong Z, He L, Kang L, Wu Y, Chen B, Jiang Q.
    Medicine (Baltimore); 2020 Dec 18; 99(51):e23679. PubMed ID: 33371107
    [Abstract] [Full Text] [Related]

  • 8. The effect of prednisone on the progression from ocular to generalized myasthenia gravis.
    Monsul NT, Patwa HS, Knorr AM, Lesser RL, Goldstein JM.
    J Neurol Sci; 2004 Feb 15; 217(2):131-3. PubMed ID: 14706214
    [Abstract] [Full Text] [Related]

  • 9. Efficacy and safety of tacrolimus in Osserman grade III and Osserman grade IV Myasthenia Gravis.
    Zhao LN, Liang Y, Fang XJ, Liu XM, Jiang QL, Wang SS, She SF, Cao M.
    Clin Neurol Neurosurg; 2018 Oct 15; 173():70-76. PubMed ID: 30092406
    [Abstract] [Full Text] [Related]

  • 10. [Analysis for the effect of different regimens on ocular myasthenia gravis in children].
    Liu C, Wang X, Xie L, Peng J, Wu L, Zheng X.
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2017 Nov 28; 42(11):1275-1279. PubMed ID: 29187654
    [Abstract] [Full Text] [Related]

  • 11. Depression: A Contributing Factor to the Clinical Course in Myasthenia Gravis Patients.
    Mihalache OA, Vilciu C, Petrescu DM, Petrescu C, Manea MC, Ciobanu AM, Ciobanu CA, Popa-Velea O, Riga S.
    Medicina (Kaunas); 2023 Dec 28; 60(1):. PubMed ID: 38256317
    [Abstract] [Full Text] [Related]

  • 12. Celebrating the 70 years of pyridostigmine on therapy of Myasthenia Gravis: historical aspects of the preliminary trials.
    Lorenzoni PJ, Kay CSK, Ducci RD, Fustes OJH, Werneck LC, Scola RH.
    Arq Neuropsiquiatr; 2020 Mar 28; 78(3):179-181. PubMed ID: 32215460
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Successful desensitization protocol for pyridostigmine in a 12 year old patient with myasthenia gravis.
    Kaplan F, Topal E.
    Turk J Pediatr; 2023 Mar 28; 65(2):326-329. PubMed ID: 37114698
    [Abstract] [Full Text] [Related]

  • 15. Remission and relapses of myasthenia gravis on long-term tacrolimus: a retrospective cross-sectional study of a Chinese cohort.
    Bi Z, Cao Y, Liu C, Gui M, Lin J, Zhang Q, Li Y, Ji S, Bu B.
    Ther Adv Chronic Dis; 2022 Mar 28; 13():20406223221122538. PubMed ID: 36093262
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The natural history and ophthalmic involvement in childhood myasthenia gravis at the hospital for sick children.
    Mullaney P, Vajsar J, Smith R, Buncic JR.
    Ophthalmology; 2000 Mar 28; 107(3):504-10. PubMed ID: 10711889
    [Abstract] [Full Text] [Related]

  • 19. Comparative effectiveness and safety of intravenous methylprednisolone and tacrolimus monotherapy in ocular myasthenia gravis with unsatisfactory prednisone responses: a retrospective study.
    Zhang KY, Duan WW, Luo YB, Li Y, Hu J, Yang H.
    Orphanet J Rare Dis; 2024 Jan 19; 19(1):19. PubMed ID: 38243274
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.